Watchlist Price Alert

Taisho Pharmaceutical Co... (TAIPY)

PNK: TAIPY · Real-Time Price · USD

14.00

null (null%)

At close: Jul 12, 2024, 8:00 PM

Taisho Pharmaceutical Income Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	83.58B	82.3B	80.8B	73.71B	83.15B	75.45B	69.07B	68.15B	69.89B	66.28B	63.88B	67.84B	68.25B	70.88B	75.07B	77.29B	79.11B	71.98B	60.34B	61.44B	70.36B	67.72B	61.84B	64.86B	77.3B	69.45B	68.53B	63.4B	75.37B	71.54B	69.44B	65.56B	78.7B	76.54B	69.16B
Cost of Revenue	37.1B	35.38B	32.52B	32.22B	33.12B	30.92B	27.26B	26.52B	26.21B	27.49B	24.14B	28.53B	25.15B	24.53B	27.84B	31.25B	32.7B	25.35B	19.04B	22.1B	24.85B	22.97B	21.3B	22.57B	26.16B	24.19B	24.23B	23.54B	27.34B	25.61B	25.03B	25.13B	31.42B	29.9B	26.7B
Gross Profit	46.48B	46.91B	48.28B	41.49B	50.03B	44.53B	41.8B	41.63B	43.68B	38.78B	39.74B	39.32B	43.09B	46.35B	47.23B	46.04B	46.4B	46.63B	41.3B	39.34B	45.52B	44.76B	40.55B	42.28B	51.14B	45.26B	44.3B	39.86B	48.03B	45.92B	44.41B	40.43B	47.28B	46.64B	42.47B
Operating Income	2.66B	7.29B	9.07B	-106M	10.92B	6.95B	5.25B	3.61B	4.82B	-363M	2.68B	-899M	4.57B	6.91B	9.39B	3.89B	2.89B	6.35B	8.32B	3.1B	11.13B	8.83B	8.16B	8.42B	13.38B	8.24B	6.94B	5.41B	9.9B	7.55B	9.11B	6.16B	8.8B	8.69B	5.23B
Interest Income	743M	718M	555M	434M	445M	389M	324M	324M	334M	337M	343M	345M	373M	434M	538M	658M	873M	1.06B	1.18B	1.21B	1.23B	1.24B	1.27B	1.27B	1.26B	1.26B	1.21B	1.25B	1.94B	1.28B	1.35B	1.36B	1.35B	1.33B	1.34B
Pretax Income	4.46B	5.92B	7.1B	-402M	12.63B	8.06B	9.21B	5.88B	9.24B	2.27B	4B	-1.19B	5.77B	7.58B	10.82B	3.95B	5.4B	7.21B	13.74B	-1.76B	12.76B	41.28B	12.2B	8.39B	21.11B	9.04B	9.53B	7B	14.55B	10.07B	10.34B	6.81B	11.42B	10.18B	7.4B
Net Income	2.87B	3.09B	4.36B	-1.9B	10.02B	5.13B	5.75B	4.15B	6.07B	1.73B	1.18B	-919M	2.94B	5.23B	6.06B	2.6B	2.95B	3.97B	11.01B	-2.81B	8.96B	28.75B	13.69B	5.22B	14.45B	6.48B	5.53B	5.11B	10.17B	6.55B	6.95B	3.77B	7.42B	6.59B	4.69B
Selling & General & Admin	38.04B	34.56B	34.5B	35.49B	34.09B	32.78B	31.74B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Research & Development	5.79B	5.07B	4.71B	6.11B	5.02B	4.79B	4.81B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	198M	46M	-29M	122M	94M	46M	60M	25M	-261M	105M	-5M	-268M	26M	339M	238M	-31M	60M	90M	51M	117M	142M	347M	497M	106M	226M	134M	168M	146M	174M	140M	146M	149M	186M	81M	270M
Operating Expenses	43.82B	39.63B	39.21B	41.6B	39.11B	37.58B	36.55B	38.02B	38.86B	39.15B	37.06B	40.22B	38.53B	39.44B	37.84B	42.15B	43.51B	40.28B	32.98B	36.25B	34.39B	35.92B	32.39B	33.86B	37.76B	37.02B	37.36B	34.46B	38.13B	38.38B	35.3B	34.27B	38.48B	37.95B	37.23B
Interest Expense	85M	62M	47M	22M	55M	64M	28M	61M	54M	34M	21M	56M	36M	33M	31M	84M	18M	16M	n/a	n/a	1M	n/a	1M	1M	n/a	1M	n/a	1M	n/a	1M	n/a	1M	n/a	1M	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	49.46B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	80.92B	75.01B	71.73B	73.82B	72.23B	68.5B	63.81B	64.54B	65.07B	66.64B	61.21B	68.74B	63.68B	63.97B	65.67B	73.4B	76.22B	65.63B	52.02B	58.34B	59.24B	58.89B	53.68B	56.44B	63.92B	61.21B	61.59B	58B	65.46B	63.99B	60.33B	59.4B	69.91B	67.85B	63.92B
Income Tax Expense	1.16B	2.24B	1.79B	972M	1.94B	2.39B	2.9B	1.38B	2.75B	19M	2.3B	-479M	2.28B	1.85B	4.13B	999M	1.74B	3.27B	2.41B	796M	3.49B	12.26B	-1.89B	2.7B	6.12B	2.4B	3.48B	1.89B	3.85B	3.16B	2.85B	2.95B	3.48B	3.15B	2.35B
Shares Outstanding (Basic)	81.97M	81.98M	81.98M	81.98M	81.98M	328.37M	327.94M	328.3M	327.95M	327.95M	319.27M	319.26M	319.27M	319.27M	319.25M	319.26M	319.26M	319.26M	319.26M	319.26M	319.27M	319.28M	319.28M	319.4M	319.59M	319.61M	319.62M	319.62M	319.63M	319.64M	319.64M	321.8M	324.27M	324.27M	324.24M
Shares Outstanding (Diluted)	82.09M	82.1M	82.09M	81.98M	82.09M	328.37M	328.25M	328.3M	328.3M	328.29M	319.73M	319.6M	319.76M	319.63M	319.62M	319.64M	319.65M	319.69M	319.55M	319.58M	319.59M	319.58M	319.56M	319.7M	319.87M	319.91M	319.84M	319.88M	319.87M	319.86M	319.83M	321.99M	324.49M	324.44M	324.4M
EPS (Basic)	35.05	37.66	53.22	-23.2	122.25	15.61	17.54	12.63	18.62	5.29	3.70	-2.88	9.21	16.38	19.00	7.45	9.43	11.83	34.48	-8.79	28.08	90.03	42.88	16.34	45.20	20.28	17.32	15.99	31.82	20.50	21.73	11.75	22.90	20.34	14.45
EPS (Diluted)	35.00	37.60	53.15	-23.2	122.09	15.61	17.52	12.63	18.60	5.29	3.69	-2.88	9.20	16.36	18.97	7.44	9.41	11.81	34.44	-8.78	28.05	89.95	42.84	16.32	45.17	20.26	17.30	15.98	31.80	20.49	21.72	11.75	22.88	20.33	14.45
EBITDA	4.55B	8.03B	15.24B	6.61B	17.16B	8.13B	11.02B	5.95B	10.35B	2.3B	8.07B	1.31B	8.74B	7.61B	11.15B	4.04B	5.42B	7.23B	13.74B	4.69B	12.76B	10.51B	12.2B	8.76B	15.53B	9.04B	9.53B	8.32B	14.55B	10.41B	10.34B	7.68B	11.42B	11.78B	7.4B
EBIT	4.55B	5.99B	7.14B	-380M	12.68B	8.13B	9.24B	5.95B	9.3B	2.3B	4.03B	-1.13B	5.8B	7.61B	10.85B	4.04B	5.42B	7.23B	13.74B	-1.76B	12.76B	41.28B	12.2B	8.39B	21.11B	9.04B	9.53B	7B	14.55B	10.07B	10.34B	6.81B	11.42B	10.18B	7.4B
Depreciation & Amortization	2.07B	743M	6.95B	6.72B	6.25B	743M	2.1B	1.43B	962M	1.21B	4.02B	3.37B	2.5B	589M	1.38B	2.21B	1.35B	870M	1.76B	233M	3.12B	989M	-674M	340M	2.15B	817M	1.85B	1.25B	2.34B	1.16B	1.31B	1.52B	2.62B	1.5B	2.26B